Published in Healthcare Mergers, Acquisitions and Ventures Week, October 15th, 2005
Additional data were presented showing improvements in markers associated with cardiovascular risk factors, including lipids and blood pressure through a 1.5 of treatment. The findings were presented at the 41st annual meeting of the European...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Healthcare Mergers, Acquisitions and Ventures Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.